Comparative evaluation of different doses of intrathecal neostigmine as an adjuvant to bupivacaine for postoperative analgesia

Vandana Pandey, B K Mohindra, Gurdip Singh Sodhi, Vandana Pandey, B K Mohindra, Gurdip Singh Sodhi

Abstract

Objective: To study the efficacy and safety of intrathecal neostigmine at dose of 50 μg and 150 μg as an adjuvant to bupivacaine for postoperative analgesia under spinal anesthesia.

Materials and methods: 75 patients of either sex, belonging to American Society of Anesthesiologists (ASA) physical status I and II in the age group of 30-65 years scheduled to undergo lower abdominal and lower limb surgeries were allocated randomly into 3 groups of 25 each. Spinal anesthesia was administered in Group I (control group) with 12.5 mg (2.5 ml) of 0.5% hyperbaric bupivacaine, in Group II (50 μg group) with 12.5 mg (2.5 ml) of 0.5% hyperbaric bupivacaine and 50 μg (0.1 ml) of neostigmine methylsulphate and in Group III (150 μg group) with 12.5 mg (2.5 ml) of 0.5% hyperbaric bupivacaine and 150 μg (0.3 ml) of neostigmine methylsulphate. Hemodynamic parameters, onset and level of sensory block were recorded. Postoperative analgesic assessment was made in terms of total Visual Analogue Scale-Pain (VAS-P) scores in 24 hrs, duration of analgesia (time to requirement of first analgesic) and total number of rescue analgesic (diclofenac sodium 75 mg intramuscularly) consumption in 24 hours. Side effects were recorded.

Results: The total VAS-P score in group I was 23.12 ± 3.21, which was higher than the VAS-P score in group II (18.4 ± 2.92) and group III (16.24 ± 1.85). The total duration of analgesia was significantly prolonged in neostigmine groups (224.40 ± 23.28 min in group I, 367.60 ± 42.15 min in group II and 625.60 ± 87.70 min in group III). In group I, the patients required 2.48 ± 0.51 number of analgesics in 24 hours, which was much higher than required in group II (1.92 ± 0.64) and group III (1.32 ± 0.47). The incidence of nausea and vomiting was more with 150 μg neostigmine group compared to 50 μg neostigmine.

Conclusions: The administration of intrathecal neostigmine in dose of 50 μg as an adjuvant to bupivacaine produces hemodynamically stable analgesia with minimal side effects.

Keywords: Intrathecal neostigmine; postoperative analgesia; visual analog scale for pain.

Figures

Figure 1
Figure 1
Mean visual analog scale for pain score
Figure 2
Figure 2
Mean visual analog scale for nausea score
Figure 3
Figure 3
Adverse effects

References

    1. Merskey H, Albe-Fessard DG, Bonica JJ, Carmon A, Dubner R, Kerrf WL, et al. Pain terms: A list with definition and notes on usage, recommended by the IASP subcommittee on taxonomy. Pain. 1979;6:249–52.
    1. Tan PH, Chia YY, Lo Y, Liu K, Yang LC, Lee TH. Intrathecal bupivacaine with morphine or neostigmine for postoperative analgesia after total knee replacement surgery. Can J Anaesth. 2001;48:551–6.
    1. Bouderka MA, Al-Harrar R, Bouaggad A, Harti A. Neostigmine added to bupivacaine in axillary plexus block: Which benefit? Ann Fr Anesth Reanim. 2003;22:510–3.
    1. Turan A, Memis D, Basaran UN, Karamanlioglu B, Süt N. Caudal ropivacaine and neostigmine in pediatric surgery. Anesthesiology. 2003;98:719–22.
    1. Naguib M, Yaksh TL. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology. 1994;80:1338–48.
    1. De rosa RC, De Robertis E, Ughi L, Lanza A, Palomba R. Is the use of intrathecal neostigmine for postoperative analgesia worthwhile? Br J Anaesth. 1996;2:76.
    1. Lauretti GR, Reis MP, Prado WA, Klamt JG. Dose-response study of intrathecal morphine versus intrathecal neostigmine, their combination, or placebo for postoperative analgesia in patients undergoing anterior and posterior vaginoplasty. Anesth Analg. 1996;82:1182–7.
    1. Yaksh TL, Dirksen R, Harty GJ. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol. 1985;117:81–8.
    1. Krukowski JA, Hood DD, Eisenach JC, Mallak KA, Parker RL. Intrathecal neostigmine for post-cesarean section analgesia: Dose response. Anesth Analg. 1997;84:1269–75.
    1. Kremer M. Action of intrathecally injected prostigmine acetylcholine, and eserine on the central nervous system in man. J Exp Physiol. 1942;31:337–57.
    1. Flodmark S, Wrammer T. The analgesic action of morphine, eserine and prostigmine studied by a modified Handy-Wolff-Goodel method. Acta Physiol Scand. 1945;9:88–96.
    1. Pleuvry BJ, Tobias MA. Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Br J Pharmacol. 1971;43:706–14.
    1. Nistri A, Pepeu G, Cammelli E, Spina L, De Bellis AM. Effects of morphine on brain and spinal acetylcholine levels and nociceptive threshold in the frog. Brain Res. 1974;80:199–209.
    1. Saini S, Sethi S, Malhotra N. Evaluation of intrathecal neostigmine for postoperative analgesia. J Anaesth Clin Pharmacol. 2005;21:419–24.
    1. Tan PH, Kuo JH, Liu K, Hung CC, Tsai TC, Deng TY. Efficacy of intrathecal neostigmine for the relief of postinguinal hemiorrhaphy pain. Acta Anaesthesiol Scand. 2000;44:1056–60.
    1. Martyr JW, Clark MX. Hypotension in elderly patients undergoing spinal anaesthesia for repair of fractured neck of femur. A comparison of two different spinal solutions. Anaesth Intensive Care. 2001;29:501–5.
    1. Hood DD, Eisenach JC, Tuttle R. Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology. 1995;82:331–43.
    1. Liu SS, Hodgson PS, Moore JM, Trautman WJ, Burkhead DL. Dose-response effects of spinal neostigmine added to bupivacaine spinal anesthesia in volunteers. Anesthesiology. 1999;90:710–7.
    1. Lauretti GR, Hood DD, Eisenach JC, Pfeifer BL. A multi-center study of intrathecal neostigmine for analgesia following vaginal hysterectomy. Anesthesiology. 1998;89:913–8.
    1. Khan ZH, Hamidi S, Miri M, Majedi H, Nourijelyani K. Post-operative pain relief following intrathecal injection of acetylcholine esterase inhibitor during lumbar disc surgery: A prospective double blind randomized study. J Clin Pharm Ther. 2008;33:669–75.
    1. Chittora SP, Ahmed F, Sharma R. A comparative analysis of neostigmine as an additive to lignocaine for postoperative analgesia is intrathecal and epidural anaesthesia. Indian J Anaesth. 2003;47:185–9.
    1. Gupta S. Postoperative analgesia with intrathecal neostigmine; two different doses of 75 µgms and 50 µgms with heavy bupivacaine. Internet J Anaesthesiol. 2010;25:1.
    1. Klamt JG, Slullitel A, Garcia IV, Prado WA. Postoperative analgesic effect of intrathecal neostigmine and its influence on spinal anaesthesia. Anaesthesia. 1997;52:547–51.
    1. Lauretti GR, Reis MP. Subarachnoid neostigmine does not affect blood pressure or heart rate during bupivacaine spinal anaesthesia. Reg Anesth. 1996;21:586–91.
    1. Carp H, Jayaram A, Morrow D. Intrathecal cholinergic agonists lessen bupivacaine spinal-block-induced hypotension in rats. Anesth Analg. 1994;79:112–6.
    1. Eisenach JC, Grice SC, Dewan DM. Epinephrine enhances analgesia produced by epidural bupivacaine during labor. Anesth Analg. 1987;66:447–51.
    1. Lauretti GR, Azevedo VM. Intravenous ketamine or fentanyl prolongs postoperative analgesia after intrathecal neostigmine. Anesth Analg. 1996;83:766–70.
    1. Chung CJ, Kim JS, Park HS, Chin YJ. The efficacy of intrathecal neostigmine, intrathecal morphine, and their combination for post-cesarean section analgesia. Anesth Analg. 1998;87:341–6.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner